Creation of dedicated discovery unit at AblynxDiscovery and development of Nanobodies® against multiple targets in Merck Serono’s core therapeutic areas
28 September, 2013
Imperial Innovations Group plc, a leading technology commercialisation and investment group, announces that portfolio company Cell Medica, a leading T cell therapeutics company, has opened a European manufacturing facility in Berlin-Buch, Germany.
27 September, 2013
New York Academy of Sciences, in partnership with The Global CEO Initiative on Alzheimer’s Disease and the National Institute on Aging/NIH, to Launch “Path to 2025” Biennial Summit to Drive Progress in Alzheimer’s R&D over Next Decade
24 September, 2013
Molecular Profiles, one of The University of Nottingham’s longest established spin-out businesses, has been purchased by Columbia Laboratories, Inc. (Nasdaq: CBRX) of Boston, for approximately $25m (£16m).Molecular Profiles was established in 1997 by an academic group at The University of Nottingham’s School of Pharmacy, who identified an opportunity to deliver sophisticated analytical and development solutions to meet the growing needs of the pharmaceutical industry.
22 September, 2013
ClinTec International, the global Clinical Research Organisation has been named as a finalist for the accolade of ‘Best CRO’ at the SCRIP Awards 2013, to be held in London’s Lancaster Hotel on November 21st, 2013. Being on the final shortlist for this accolade, at what is one of the biggest ceremonies in the pharmaceutical industry, marks a further landmark in what has been a successful year for the company.
19 September, 2013
Cancer Research Technology Ltd. (CRT), Cancer Research UK’s technology development arm, and Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) have signed a multi-project alliance agreement to research and develop first-in-class cancer drugs that modulate DNA damage and repair response (DDR) processes in cancer cells.
16 September, 2013
Worldwide hearing implant leader MED-EL Medical Electronics today announced that its Founder and CEO Ingeborg Hochmair, PhD, has been selected to receive this year's prestigious Lasker-DeBakey Clinical Medical Research Award for the development of the modern cochlear implant, a device that restores hearing to individuals with severe-to-profound deafness through electrical stimulation of the auditory nerve. She will share the award with Graeme M. Clark (Emeritus, Univ. of Melbourne, Australia) and Blake S. Wilson (Duke University, NC, USA). This highly-respected scientific award honors scientists whose contributions have improved the clinical treatment of patients. The award ceremony will take place in New York City on Friday, September 20, 2013
15 September, 2013
Zealand Pharma has announced an exclusive peptide drug research and development collaboration agreement with Eli Lilly and Company (“Lilly”).
10 September, 2013
Researchers at the University of Leuven (KU Leuven) are joining forces with Janssen Pharmaceuticals Inc. (Janssen) and the Wellcome Trust to discover and develop candidate antiviral drugs for the prevention and treatment of dengue infection.
03 September, 2013